Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting
-
* Corresponding author: Sarah J Freemantle Sarah.Freemantle@dartmouth.edu
BMC Cancer 2009, 9:383 doi:10.1186/1471-2407-9-383
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 17 Mar 2009 | |
| Reviewer's Report | Michael kahn | 31 Mar 2009 | |
| Reviewer's Report | Raymond Habas | 08 Apr 2009 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 23 Jul 2009 |
| Reviewer's Report | Raymond Habas | 11 Aug 2009 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 03 Sep 2009 |
| Editorial acceptance | 04 Sep 2009 | ||
| Published | 29 Oct 2009 |